292
Participants
Start Date
March 31, 2008
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
mifepristone
1200 mg (administered as four 300 mg tablets) once a day by mouth for the initial 7 days
placebo
Tablets of identical appearance to active drug, once a day by mouth for the initial 7 days
The Zucker Hillside Hospital, Glen Oaks
Neurobehavioral Research, Inc., Cedarhurst
University of Pittsburgh Medical Center (UPMC), Pittsburgh
Lehigh Center for Clinical Research, Allentown
Belmont Center for Comprehensive Treatment, Philadelphia
Wake Forest University Baptist Medical Center, Winston-Salem
Inquest Clinical Group/ Global Research Associates, Hope Mills
Carolina Clinical Trials, Inc., Charleston
Atlanta Center for Medical Research, Atlanta
University of Florida, Gainesville
Lakeside Behavioral Health, Orlando
Segal Institute for Clinical Research, Hollywood
AMB Research Center, Miami
Professional Clinical Research, Inc., Aventura
University of South Florida Dept of Psychiatry and Neurosciences, Tampa
Accurate Clinical Trials, Kissimmee
Precise Research Centers, Flowood
Midwest Clinical Research Center, Dayton
Alexian Brothers Center for Psychiatric Research, Hoffman Estates
PsychCare Consultants Research, St Louis
Millennium Psychiatric Associate, Creve Coeur
K&S Professional Research Services, LLC, Little Rock
Woodland International Research Group, Inc., Little Rock
Oklahoma Clinical Research Center, Oklahoma City
InSite Clinical Research, LLC, DeSoto
Pillar Clinical Research, LLC, Dallas
University of Texas Southwestern Medical Center, Dallas
Claghorn-Lesem Research Clinic, Houston
Clinical Trial Network, Houston
Fein-Jennings Clinic, Inc., Houston
FutureSearch Clinical Trials, L.P., Austin
Lifetree Clinical Research, Salt Lake City
Diligent Clinical Trials, Downey
Synergy Clinical Research Center, Escondido
North County Clinical Research, Oceanside
Sharp Mesa Vista Hospital, San Diego
Cnri, Llc, San Diego
Breakthrough Clinical Trials, San Bernardino
South Coast Clinical Trials, Inc, Anaheim
Collaborative Neuroscience Network, Inc., Garden Grove
Pacific Research Partners, Oakland
CRI Lifetree, Marlton
Lead Sponsor
Corcept Therapeutics
INDUSTRY